Literature DB >> 25178886

Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke.

Deanne Soares1, Richard Bullock1, Susanna Ali2.   

Abstract

Summary We report a case with interesting imaging findings as well as an unfortunate but not unexpected clinical outcome. Our patient, an 8-year-old Jamaican boy of Afro-Caribbean descent with homozygous sickle cell disease, presented with left-sided upper limb weakness. He had a history of recurrent cerebrovascular accidents and transient ischaemic attacks beginning at 4 years of age. MRI revealed old bilateral infarctions and the ivy sign on fluid-attenuated inversion recovery sequences. MR angiography demonstrated numerous collaterals, most apparently arising from the left internal carotid, consistent with moyamoya syndrome. The patient had a full recovery and remained well for almost 2 years when he suffered another stroke. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25178886      PMCID: PMC4158242          DOI: 10.1136/bcr-2014-203727

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  46 in total

Review 1.  Moyamoya disease: a review of histopathology, biochemistry, and genetics.

Authors:  David G Weinberg; Omar M Arnaout; Rudy J Rahme; Salah G Aoun; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  Occlusion of large cerebral vessels in sickle-cell anemia.

Authors:  J A Stockman; M A Nigro; M M Mishkin; F A Oski
Journal:  N Engl J Med       Date:  1972-10-26       Impact factor: 91.245

3.  "Ivy sign" in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images.

Authors:  Hye-Kyung Yoon; Hyung-Jin Shin; Yun Woo Chang
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

4.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

5.  Decrease in leptomeningeal ivy sign on fluid-attenuated inversion recovery images after cerebral revascularization in patients with Moyamoya disease.

Authors:  M Kawashima; T Noguchi; Y Takase; Y Nakahara; T Matsushima
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-13       Impact factor: 3.825

6.  Multiple intracranial arterial occlusions (moyamoya disease) in patients with neurofibromatosis. One case report with autopsy.

Authors:  E Lamas; R Diez Lobato; A Cabello; J M Abad
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

7.  A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy.

Authors:  K R Bridges; G D Barabino; C Brugnara; M R Cho; G W Christoph; G Dover; B M Ewenstein; D E Golan; C R Guttmann; J Hofrichter; R V Mulkern; B Zhang; W A Eaton
Journal:  Blood       Date:  1996-12-15       Impact factor: 22.113

8.  Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke.

Authors:  Susanna Bortolusso Ali; Michelle Moosang; Lesley King; Jennifer Knight-Madden; Marvin Reid
Journal:  Am J Hematol       Date:  2011-09-02       Impact factor: 10.047

Review 9.  Stroke in children.

Authors:  S G Pavlakis; R J Gould; J L Zito
Journal:  Adv Pediatr       Date:  1991

10.  Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.

Authors:  Raphael Guzman; Marco Lee; Achal Achrol; Teresa Bell-Stephens; Michael Kelly; Huy M Do; Michael P Marks; Gary K Steinberg
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

View more
  2 in total

1.  Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion.

Authors:  Shin-Young Park; Alessandro Matte; Yookyung Jung; Jina Ryu; Wilson Babu Anand; Eun-Young Han; Min Liu; Carmine Carbone; Davide Melisi; Takashi Nagasawa; Joseph J Locascio; Charles P Lin; Leslie E Silberstein; Lucia De Franceschi
Journal:  Blood       Date:  2020-06-04       Impact factor: 25.476

Review 2.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.